Assessment of Pain in Surgical Patient by PMD 200
1 other identifier
interventional
25
0 countries
N/A
Brief Summary
The trial will estimate post-operative pain management in elective surgical patients using the PMD-200 device. The device measures physiological parameters by placing a non-invasive sensor on a fingertip and displays an objective pain level in a 0-100 scale. The pain level will be estimated before surgery (baseline), after surgery and during administration of parenteral analgesia. Treatment and analgesia will be given according to clinical considerations and standard ward protocols. The device measurements won't influence the treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2017
CompletedFirst Posted
Study publicly available on registry
August 17, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedAugust 21, 2017
August 1, 2017
10 months
August 11, 2017
August 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pain level estimation by 1-100 scale by non invasive finger sensor
a finger sensor will estimate the pain by a numerical scale of 1-100 in which 1 stand for no pain and 100 stand for severe pain.
up to 7 months
Interventions
finger sensor which estimate objectively the pain level
Eligibility Criteria
You may qualify if:
- Age 18-100
- Elective patient for laparoscopic cholecystectomy
- Absence of acute or chronic pain
You may not qualify if:
- Pregnancy
- Dementia and mental retardation
- Drugs that influence the autonomic system as beta blocker
- Arrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
haim Paran, MD
clalit
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 11, 2017
First Posted
August 17, 2017
Study Start
September 1, 2017
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
August 21, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share